News

Torx Software Limited, announces a collaboration with CDD Vault to facilitate the seamless synthesis and registration of new compounds during the small-molecule drug discovery process. Torx is a cloud-based platform developed by Cresset and Elixir™ Software, which enables chemistry teams...

The United Kingdom has once again become a part of Horizon Europe through a fresh agreement with the European Union. This development opens up opportunities for British scientists to engage in the world's largest research and development collaboration program....

After undergoing an inspection by the UK Medicines & Healthcare Products Regulatory Agency (MHRA), Rentschler Biopharma SE's UK facility for advanced therapy medicinal products (ATMP) has been granted a Manufacturing Compliance Certificate in accordance with current good manufacturing practice...

Small and medium-sized enterprises (SMEs) often encounter unfair competition while conducting business in Europe. To rectify this issue, the European Commission (EC) has introduced new measures through SME Relief Communication. These measures offer immediate relief, enhance long-term competitiveness, and...

The initial findings from the CPHI Annual Report for 2023, which offers insights from 250 global pharmaceutical companies, indicate that artificial intelligence (AI) is poised to revolutionize every aspect of the pharmaceutical industry, from drug discovery to drug development,...

The Cell and Gene Therapy Catapult is embarking on a two-year project in collaboration with two other organizations, namely contract development and manufacturing organization (CDMO) Rentschler Biopharma and Refeyn Ltd. Their objective is to enhance the manufacturing process of...

As per the US Federal Trade Commission (FTC), Amgen is prohibited from using its drug portfolio to unfairly disadvantage its competitors in the industry. The biopharmaceutical company will need to obtain prior approval before acquiring related products. The FTC has...